[D]octors without Borders (Médecins Sans Frontières or MSF) will begin trials of three therapies starting next month in West Africa. Here’s how those trials will break down: The French National Institute of Health and Medical Research (INSERM) will use the antiviral drug favipiravir in Guéckédou, Guinea. The Antwerp Institute of TropicalContinue Reading